anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
NeuroSense Therapeutics · pitchdeck

NeuroSense Therapeutics | Investor Presentation Deck | 27 slides

27 pages · 4 arc beats · 0 loops

Pitchdeck Download JSON
Unlock

NeuroSense Therapeutics | Investor Presentation Deck | 27 slides

NeuroSense Therapeutics · 2024-10
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 15 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem Statement 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 15 hits
— 0/2 slides
100% 2/2 slides · 3 hits
— 0/2 slides
100% 2/2 slides
— 0/2 slides
Traction 11 slides 100% 11/11 slides 100% 11/11 slides · 61 hits
— 0/11 slides
90.9% 10/11 slides · 11 hits 9.1% 1/11 slides 100% 11/11 slides
— 0/11 slides
Market Sizing 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

27
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a five-column icon-based layout to present key value propositions.summarize
Open slide detail
04
The slide uses a standard pharmaceutical pipeline visualization format.plan_implementation
Open slide detail
05
other
Open slide detail
06
The slide uses a grid layout to showcase the board members with headshots, credentials, and associated logos.other
Open slide detail
07
Uses a 'before and after' visual comparison of a patient's health progression over time.frame_problem
Open slide detailBeat · Problem Statement
08
The slide uses a three-column layout to explain the biological mechanisms of the drug combination.present_solution
Open slide detailBeat · Solution
09
The slide shows a pharmacokinetic study in mice comparing Ciprofloxacin alone vs. combination therapy.present_solution
Open slide detailBeat · Solution
10
Includes statistical significance markers (*, ***) and source citation.show_traction
Open slide detailBeat · Traction
11
Includes a collaboration credit with Dr. Justin Ichida at USC.show_traction
Open slide detailBeat · Traction
12
Includes box plots for baseline comparison and line charts for longitudinal treatment effects.show_traction
Open slide detailBeat · Traction
13
Includes a flow diagram of the trial phases and a table of baseline characteristics.present_framework
Open slide detailBeat · Traction
14
The slide highlights safety data; the bottom text emphasizes that adverse events were transient and anticipated.show_traction
Open slide detailBeat · Traction
15
Includes statistical significance markers and sample sizes (N) for each time point.show_traction
Open slide detailBeat · Traction
16
Includes both a longitudinal line chart and a bar chart comparing total points lost at 12 months.show_traction
Open slide detailBeat · Traction
17
The slide compares 'DB' (Double Blind) and 'DB+OLE' (Double Blind + Open Label Extension) periods across four functional domains.show_traction
Open slide detailBeat · Traction
18
The slide notes 'n.s.' (not statistically significant) for all metrics. The footer defines SVC and Survival calculation methodology.show_traction
Open slide detailBeat · Traction
19
Includes longitudinal biomarker charts and correlation scatter plots with p-values.show_traction
Open slide detailBeat · Traction
20
The slide uses a bulleted list to present key clinical trial outcomes, including p-values and percentage improvements.show_traction
Open slide detailBeat · Traction
21
KOL = Key Opinion Leadershow_traction
Open slide detail
22
size_opportunity
Open slide detailBeat · Market Sizing
23
The slide uses a process-oriented visual to outline the study parameters and the three key focus areas (Safety, Efficacy, Biomarkers).plan_implementation
Open slide detail
24
plan_implementation
Open slide detail
25
The slide uses a list of four key value propositions for the drug candidate PrimeC.present_solution
Open slide detail
26
The slide uses emotional appeal to establish credibility and mission alignment.inspire_vision
Open slide detail
27
This is a standard closing/contact slide.other
Open slide detail